Sensitivity of mycobacterium leprae to telacebec
The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae wa...
Saved in:
Main Authors: | Lahiri, Ramanuj, Adams, Linda B., Thomas, Sangeeta Susan, Pethe, Kevin |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
The Qcrb inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus
by: Sorayah, Ria, et al.
Published: (2022) -
Naturally-occurring polymorphisms in QcrB are responsible for resistance to Telacebec in Mycobacterium abscessus
by: Sorayah, Ria, et al.
Published: (2021) -
A case study of three cured lepers in Tala Leprosarium
by: Lo, Ricardo C., et al.
Published: (1984) -
Structure-based virtual screening of Philippine natural products to discover novel inhibitors against mycobacterium leprae MurE ligase
by: Hsiao, Vivien B., et al.
Published: (2026) -
Analysis of HLA class II allele frequencies in leprosy patients from central Thailand
by: Duangporn Srinak
Published: (2023)